401
Views
22
CrossRef citations to date
0
Altmetric
Articles

Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital

, , , , &
Pages 21-29 | Received 16 Feb 2016, Accepted 24 Jul 2016, Published online: 06 Sep 2016

References

  • World Health Organization. The World Health Report 2005: make every mother and child count. Geneva: World Health Organization; 2005.
  • Duley L. The global impact of preeclampsia and eclampsia. Semin Perinatol 2009;33:130–137.
  • Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159–167.
  • Sibai BM. The HELLP Syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990;162:311–316.
  • Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460–464.
  • Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000–1006.
  • Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 2004;103:981–991.
  • Abroug F, Boujdaria R, Nouira S, Abroug S, Souissi M, Najjar MF, Secourgeon JF, Bouchoucha S. HELLP syndrome: incidence and maternal-fetal outcome - a prospective study. Intensive Care Med 1992;18:274–277.
  • Rath W, Faridi A, Dudenhausen JW. HELLP syndrome. J Perinat Med 2000;28:249–260.
  • Magann EF, Martin JN Jr: Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 1999;42:532–550.
  • Suresh MS. HELLP syndrome: an anesthesiologist’s perspective. Anesth Clin North Am 1998;16:332–348.
  • Mecacci F, Carignani L, Cioni R, Paretti E, Mignosa M, Piccioli A, et al. Time course of recovery and complications of HELLP syndrome with two different treatments; heparin or dexamethasone. Throm Res 2001;102:99–105.
  • Martin JN Jr, Blake PG, Perry KGJr, McCaulJE Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991;164:1500–1509.
  • World Health Organization. WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 1977;56:247–253.
  • Engle WA. A recommendation for the definition of “late preterm” (near-term) and the birth weight-gestational age classification system. Semin Perinatol 2006;30:2–7.
  • Ferrazzani S, Guariglia L, Draisci G, et al. Postpartum hemorrhage. Minerva Ginecol 2005;57(2):111–129.
  • Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Crit Care Med 2013;41(2):580–637.
  • Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993;168:1682–1687.
  • Sibai BM, Taslimi MM, el-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155(3):501–509.
  • Martin JN Jr, Perry KG, Miles JF Jr, et al. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynecol 1993;100:1095–1100.
  • Cavkaytar S, Ugurlu EN, Karaer A, et al. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 2007;86(6):648–651.
  • Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H. Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. Sao Paulo Med J 2006;124(2):85–89.
  • Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999; 180 (1 pt 1): 221–225.
  • van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 2000;19:211–220.
  • Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A review. BMC Pregnancy and Childbirth 2009;9:8. doi. 10.1186/1471-2393-9-8.
  • Guzel AI, Kuyumcuoglu U, Celik Y. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome? Arch Gynecol Obstet 2011;283:1227–1232. doi: 10.1007/s00404-010-1524-x.
  • Gasem T, Al Jama FE, Burshaid S, et al. Maternal and fetal outcome of pregnancy complicated by HELLP Syndrome. The Journal of Maternal-Fetal and Neonatal Medicine, December 2009; 22(12): 1140–1143. doi: 10.3109/10641955.2010.507849.
  • Yildirim G, Gungorduk K, Gul A, et al. HELLP syndrome: 8 years of experience from a tertiary referral center in western Turkey. Hypertens Pregnancy. 2012;31(3):316–326.
  • Vigil-De Gracia P. Pregnancy complicated by preeclampsia-eclampsia with HELLP syndrome. Int J Gyneacol Obstet 2001;72:17–23.
  • Haddad B, Barton JR, Livingston JC, et al. Risk Facors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes,and low platelet count) syndrome. Am J Obstet Gynecol 2000;183:444–448.
  • Martin JN Jr, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hipertens Pregnancy 2012;31(1):79–90. doi: 10.3109/10641955.2010.525277.
  • Sriram S, Robertson MS. Critically ill obstetric patients in Australia: a retrospective audit of 8 years’ experience in a tertiary intensive care unit. Crit Care Resusc 2008;10:124.
  • Bezircioğlu I, Baloğlu A, Cetinkaya B, Pirim B. Do clinical and laboratory parameters effect maternal and fetal outcomes in pregnancies complicated with hemolysis, elevated liver enzymes, and low platelet count syndrome? J Turk Gynecol Assoc 2012; 1:13(1):1–7. doi: 10.5152/jtgga.2011.68.
  • Roberts WE, Perry KG Jr, Woods JB, et al. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications? Am J Obstet Gynecol 1994;171:799–804.
  • Martin JN Jr, Blake PG, Lowy SL, et al. Pregnancy complicated by preeclampsia-eclampsia with syndrome of hemolysis, elevated liver enzymes and low platelet count: How rapid is postpartum recovery? Obstet Gynecol 1990;76:737–741.
  • Catanzarite VA, Steinberg SM, Mosley CA, et al. Severe preeclampsia with fulminant and extreme elevations of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death. Am J Perinatol 1995;12:310–313.
  • Hupuczi P, Nagy B, Sziller I, et al. Characteristic laboratory changes in pregnancies complicated by HELLP syndrome. Hypertens Pregnancy 2007;26(4):389–401.
  • Isler CM, Rinehart BK, Terrone DA, et al. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999;181:924–928.
  • Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005;105:246–254.
  • Jenkins TM, Troiano NH, Graves CR, et al. Mechanical ventilation in an obstetric population: characteristics and delivery rates. Am J Obstet Gynecol 2003;188:549–552.
  • Selo-Ojeme DO, Omosaiye M, Battacharjee P, Kadir RA. Risk factors for obstetric admissions to the intensive care unit in a tertiary hospital: a case-control study. Arch Gynecol Obstet 2005;272:207–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.